Authors:
CAHN JY
LABOPIN M
SCHATTENBERG A
REIFFERS J
WILLEMZE R
ZITTOUN R
BACIGALUPO A
PRENTICE G
GLUCKMAN E
HERVE P
GRATWOHL A
GORIN NC
Citation: Jy. Cahn et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE-LEUKEMIA IN PATIENTSOVER THE AGE OF 40 YEARS, Leukemia, 11(3), 1997, pp. 416-419
Citation: P. Tiberghien et al., MODULATION OF ALLOGENEIC REACTIVITY AFTER HEMATOPOIETIC STEM-CELLS TRANSPLANTATION, MS. Medecine sciences, 13(3), 1997, pp. 312-322
Authors:
DECONINCK E
CAHN JY
MILPIED N
JOUET JP
VERNANT JP
ESPEROU H
LIOURE B
BORDIGONI P
LEBLOND V
TROUSSARD X
CAILLOT D
CORDONNIER JM
HERVE P
Citation: E. Deconinck et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA IN FIRST REMISSION - LONG-TERM RESULTS FOR 42 PATIENTS CONDITIONED WITH AN INTENSIFIED REGIMEN (TBI, HIGH-DOSE ARA-C AND MELPHALAN), Bone marrow transplantation, 20(9), 1997, pp. 731-735
Authors:
WORONOFFLEMSI MC
ARVEUX P
LIMAT S
DECONINCK E
MOREL P
CAHN JY
Citation: Mc. Woronofflemsi et al., COST COMPARATIVE-STUDY OF AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) AND BONE-MARROW (ABM) TRANSPLANTATIONS FOR NON-HODGKINS-LYMPHOMA PATIENTS, Bone marrow transplantation, 20(11), 1997, pp. 975-982
Authors:
RUMBACH L
BERGER E
TATU L
MOULIN T
CAHN JY
DUPOND JL
SCHILLINGER F
Citation: L. Rumbach et al., TRANSIENT MULTIPLE CRANIAL NERVE INVOLVEMENT AS A FIRST SIGN OF MACROPHAGE-ACTIVATION-SYNDROME, Journal of Neurology, Neurosurgery and Psychiatry, 62(3), 1997, pp. 292-293
Authors:
ROWLINGS PA
PRZEPIORKA D
KLEIN JP
GALE RP
PASSWEG JR
HENSLEEDOWNEY PJ
CAHN JY
CALDERWOOD S
GRATWOHL A
SOCIE G
ABECASIS MM
SOBOCINSKI KA
ZHANG MJ
HOROWITZ MM
Citation: Pa. Rowlings et al., IBMTR SEVERITY INDEX FOR GRADING ACUTE GRAFT-VERSUS-HOST DISEASE - RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE, British Journal of Haematology, 97(4), 1997, pp. 855-864
Authors:
SOCIE G
CAHN JY
CARMELO J
VERNANT JP
JOUET JP
IFRAH N
MILPIED N
MICHALLET M
LIOURE B
PICO JL
WITZ F
MOLINA L
FISCHER A
BARDOU VJ
GLUCKMAN E
REIFFERS J
Citation: G. Socie et al., AVASCULAR NECROSIS OF BONE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - ANALYSIS OF RISK-FACTORS FOR 4388 PATIENTS BY THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE (SFGM), British Journal of Haematology, 97(4), 1997, pp. 865-870
Authors:
FERRANT A
LABOPIN M
FRASSONI F
PRENTICE HG
CAHN JY
BLAISE D
REIFFERS J
VISANI G
SANZ MA
BOOGAERTS MA
LOWENBERG B
GORIN NC
Citation: A. Ferrant et al., KARYOTYPE IN ACUTE MYELOBLASTIC-LEUKEMIA - PROGNOSTIC-SIGNIFICANCE FOR BONE-MARROW TRANSPLANTATION IN FIRST REMISSION - A EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION STUDY, Blood, 90(8), 1997, pp. 2931-2938
Authors:
HAROUSSEAU JL
CAHN JY
PIGNON B
WITZ F
MILPIED N
DELAIN M
LIOURE B
LAMY T
DESABLENS B
GUILHOT F
CAILLOT D
ABGRALL JF
FRANCOIS S
BRIERE J
GUYOTAT D
CASASSUS P
AUDHUY B
TELLIER Z
HURTELOUP P
HERVE P
Citation: Jl. Harousseau et al., COMPARISON OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND INTENSIVE CHEMOTHERAPY AS POSTREMISSION THERAPY IN ADULT ACUTE MYELOID-LEUKEMIA, Blood, 90(8), 1997, pp. 2978-2986
Authors:
DHEDIN CN
GIRAUDIER S
ESPEROU H
MICHALLET M
IFRAH N
RIO B
CAHN JY
SUTTON L
GAULARD P
KUENTZ M
Citation: Cn. Dhedin et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR AGGRESSIVE NON-HODGKIN-LYMPHOMA (EXCEPT LYMPHOBLASTIC AND BURKITT) - A REPORT OF THE FRENCH REGISTRY, Blood, 90(10), 1997, pp. 4487-4487
Authors:
WORONOFFLEMSI MC
DEMOLY P
ARVEUX P
IFRAH N
TELLIER Z
HAROUSSEAU JL
CAHN JY
WITZ F
Citation: Mc. Woronofflemsi et al., COST-EFFECTIVENESS ANALYSIS OF GOELAM SA3, A RANDOMIZED PLACEBO-CONTROLLED PROTOCOL OF GM-SCF FOR ELDERLY PATIENTS WITH ACUTE MYELOID-LEUKEMIA, Blood, 90(10), 1997, pp. 313-313
Citation: Jy. Cahn et al., IMPACT OF CYTOSINE-ARABINOSIDE (ARA-C) DOSE GIVEN AT INDUCTION+ -CONSOLIDATION BEFORE ALLOGENEIC OR AUTOLOGOUS STEM-CELL TRANSPLANTATION (SCT) FOR ACUTE MYELOBLASTIC-LEUKEMIA IN FIRST REMISSION/, Blood, 90(10), 1997, pp. 1002-1002
Authors:
HAROUSSEAU JL
ATTAL M
PAYEN C
FACON T
MICHAUX JL
GUILHOT F
MOCONDUIT M
FUZIBET JG
CAILLOT D
DORVAUX V
CAHN JY
GROBOIS B
STOPPA AM
IFRAH N
SOTTO JJ
PIGNON B
BATAILLE R
Citation: Jl. Harousseau et al., BONE-MARROW VERSUS BLOOD AS SOURCE OF HEMATOPOIETIC STEM-CELLS AFTER HIGH-DOSE THERAPY IN MULTIPLE-MYELOMA - A PROSPECTIVE, RANDOMIZED STUDY OF THE INTERGROUPE-FRANCAIS-DU-MYELOME (IFM), Blood, 90(10), 1997, pp. 1018-1018
Authors:
LINASSIER C
CAHN JY
DESABLENS B
SENESEBE L
VILQUE JP
WITZ F
COMBE M
LUTHIER F
DECONNINCK E
MALIVOIR B
COLOMBAT P
Citation: C. Linassier et al., FIRST LINE HIGH-DOSE CHEMOTHERAPY WITH PURGED AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN ADVANCED CLL (BINET STAGE B-C) - RESULTS OF A PROSPECTIVE PHASE-II STUDY, Blood, 90(10), 1997, pp. 1030-1030
Authors:
CONTASSOT E
CARVALHO M
ANGONIN R
PAVY JJ
CAHN JY
HERVE P
TIBERGHIEN P
Citation: E. Contassot et al., ADMINISTRATION OF IRRADIATED DONOR ALLOGENEIC SPLENOCYTES ENHANCES THE ENGRAFTMENT OF AN ALLOGENEIC HEMATOPOIETIC STEM-CELL GRAFT, Blood, 90(10), 1997, pp. 1607-1607
Authors:
ATTAL M
PAYEN C
FACON T
MICHAUX JL
GUILHOT F
MOCONDUIT M
FUZIBET JG
CAILLOT D
DORVAUX V
HAROUSSEAU JL
CAHN JY
GROBOIS B
STOPPA AM
IFRAH N
SOTTO JJ
PIGNON B
BATAILLE R
Citation: M. Attal et al., SINGLE VERSUS DOUBLE TRANSPLANT IN MYELOMA - A RANDOMIZED TRIAL OF THE INTER-GROUPE-FRANCAIS-DU-MYELOME (IFM), Blood, 90(10), 1997, pp. 1859-1859
Authors:
CONTASSOT E
CARVALHO M
ROBINET E
ANGONIN R
PAVY JJ
CAHN JY
HERVE P
TIBERGHIEN P
Citation: E. Contassot et al., DIFFERENTIAL-EFFECTS OF CYCLOSPORINE-A ON THE IN-VIVO ALLOREACTIVITY OF FRESH VERSUS EX-VIVO-EXPANDED T-LYMPHOCYTES, Blood, 90(10), 1997, pp. 2380-2380
Authors:
TIBERGHIEN P
CAHN JY
FERRAND C
MILPIED N
CONTASSOT E
ANGONIN R
SALLARD D
ROBINET E
REYNOLDS CW
CERTOUX JM
ROUSSEAU E
JACOB W
HERVE P
Citation: P. Tiberghien et al., USE OF THE THYMIDINE-KINASE GENE OF THE H ERPES-SIMPLEX-1 VIRUS AS THERAPEUTIC TOOL IN TRANSPLANTATION OF BLOOD STEM-CELLS, HEM CELL TH, 38(5), 1996, pp. 464-464
Authors:
GORIN NC
LABOPIN M
FRASSONI F
PRENTICE HG
CAHN JY
REIFFERS J
BOOGAERTS M
BANDINI G
LOWENBERG B
ATTAL M
FERRANT A
Citation: Nc. Gorin et al., KARYOTYPE IN ACUTE MYELOBLASTIC-LEUKEMIA (AML) - PROGNOSTIC-SIGNIFICANCE IN BONE-MARROW TRANSPLANTATION IN FIRST REMISSION (CR-1), Experimental hematology, 24(9), 1996, pp. 545-545
Authors:
CAHN JY
HAROUSSEAU JL
PIGNON B
WITZ F
DELAIN M
LIOURE B
LAMY T
SOLARY E
DESABLENS B
BRIERE J
CASSASUS P
AUDHUY B
POLIN V
HURTELOUP P
TELLIER Z
Citation: Jy. Cahn et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IS NOT SUPERIOR TO INTENSIVE CONSOLIDATION CHEMOTHERAPY (ICC) FOR POSTREMISSION THERAPY IN ADULT ACUTE MYELOBLASTIC-LEUKEMIA (AML) - FINAL ANALYSIS OF THE GOELAMS STUDY, Experimental hematology, 24(9), 1996, pp. 671-671